Launched in 2023 with an audacious goal, XPRIZE Healthspan is a 7-year, $101 million global competition to revolutionize the way we approach human aging. The competition will incentivize Teams to develop and test therapeutics to improve healthy aging and close the gap between life expectancy and healthspan, or the period of life in reasonably good health, with autonomy, independence, and freedom from age-related disability and major chronic disease. Competing Teams will develop and test therapeutics that restore muscle, cognitive, and immune function by a minimum of 10 years, with a goal of 20 years. The winning Team of the $10M FSHD Bonus Prize must demonstrate a therapeutic treatment that restores muscle function in individuals with stable Facioscapulohumeral Muscular Dystrophy (FSHD). This report will focus only on XPRIZE Healthspan, as there is not a Semi-Finals stage for the FSHD Bonus prize.